(2012). A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder.
Chicago Style (17th ed.) CitationA Randomized, Double-blind, Placebo-controlled Trial to Assess Prevention of Mood Episodes with Risperidone Long-acting Injectable in Patients with Bipolar I Disorder. 2012.
MLA (8th ed.) CitationA Randomized, Double-blind, Placebo-controlled Trial to Assess Prevention of Mood Episodes with Risperidone Long-acting Injectable in Patients with Bipolar I Disorder. 2012.
Warning: These citations may not always be 100% accurate.